1. Home
  2. RNA vs PRVA Comparison

RNA vs PRVA Comparison

Compare RNA & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • PRVA
  • Stock Information
  • Founded
  • RNA 2012
  • PRVA 2007
  • Country
  • RNA United States
  • PRVA United States
  • Employees
  • RNA N/A
  • PRVA N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • PRVA Retail: Computer Software & Peripheral Equipment
  • Sector
  • RNA Health Care
  • PRVA Technology
  • Exchange
  • RNA Nasdaq
  • PRVA Nasdaq
  • Market Cap
  • RNA 3.6B
  • PRVA 2.7B
  • IPO Year
  • RNA 2020
  • PRVA 2021
  • Fundamental
  • Price
  • RNA $28.60
  • PRVA $23.00
  • Analyst Decision
  • RNA Strong Buy
  • PRVA Strong Buy
  • Analyst Count
  • RNA 14
  • PRVA 14
  • Target Price
  • RNA $68.00
  • PRVA $27.93
  • AVG Volume (30 Days)
  • RNA 1.4M
  • PRVA 956.3K
  • Earning Date
  • RNA 08-08-2025
  • PRVA 08-07-2025
  • Dividend Yield
  • RNA N/A
  • PRVA N/A
  • EPS Growth
  • RNA N/A
  • PRVA N/A
  • EPS
  • RNA N/A
  • PRVA 0.12
  • Revenue
  • RNA $8,927,000.00
  • PRVA $1,801,244,000.00
  • Revenue This Year
  • RNA N/A
  • PRVA $90.63
  • Revenue Next Year
  • RNA $156.80
  • PRVA $10.51
  • P/E Ratio
  • RNA N/A
  • PRVA $183.40
  • Revenue Growth
  • RNA N/A
  • PRVA 6.79
  • 52 Week Low
  • RNA $21.51
  • PRVA $16.47
  • 52 Week High
  • RNA $56.00
  • PRVA $26.09
  • Technical
  • Relative Strength Index (RSI)
  • RNA 41.42
  • PRVA 54.07
  • Support Level
  • RNA $28.36
  • PRVA $21.55
  • Resistance Level
  • RNA $30.30
  • PRVA $22.45
  • Average True Range (ATR)
  • RNA 1.79
  • PRVA 0.70
  • MACD
  • RNA -0.36
  • PRVA 0.04
  • Stochastic Oscillator
  • RNA 6.95
  • PRVA 78.17

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

About PRVA Privia Health Group Inc.

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Share on Social Networks: